Abivax S.A.
AAVXF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $392 | $450 | $888 | $562 |
| - Cash | $61 | $144 | $222 | $252 |
| + Debt | $99 | $97 | $113 | $55 |
| Enterprise Value | $429 | $403 | $779 | $365 |
| Revenue | $2 | $4 | $7 | $2 |
| % Growth | -49.7% | -41% | 202.3% | – |
| Gross Profit | $2 | $4 | $7 | $2 |
| % Margin | 100% | 100% | 100% | 83.2% |
| EBITDA | -$94 | -$92 | -$80 | -$90 |
| % Margin | -4,640.3% | -2,298% | -1,176.3% | -4,011% |
| Net Income | -$101 | -$95 | -$82 | -$96 |
| % Margin | -4,996.7% | -2,361.6% | -1,203% | -4,266.7% |
| EPS Diluted | -1.59 | -1.5 | -1.3 | -1.91 |
| % Growth | -6% | -15.4% | 31.9% | – |
| Operating Cash Flow | -$67 | -$69 | -$85 | -$70 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$67 | -$69 | -$85 | -$70 |